[Growth and puberty in type 1 diabetes mellitus - experience from a pediatric endocrinology unit]

Serviço de Pediatria. Centro Hospitalar Leiria/Pombal. Leiria. Portugal.
Acta medica portuguesa (Impact Factor: 0.36). 07/2012; 25(4):213-8.
Source: PubMed


Background: Type 1 Diabetes Mellitus (T1DM) is the most common endocrine-metabolic disease in children. It is associated with vascular and neuropathic complications, and may also affect growth and development. Objective: To correlate the metabolic control and disease duration with growth and puberty in patients with T1DM followed in a Pediatric Endocrinology Outpatient Clinic. Subjects and methods: Retrospective analysis. Sample obtained from patients with T1DM followed in Hospital Santa Maria Pediatric Endocrinology Outpatient Clinic (Lisbon - Portugal) since 1994 until March 2011. Inclusion criteria: patients diagnosed before the onset of puberty and who had attained their final height during the follow-up. Variables: sex, age, weight and height at diagnosis and final, parents' height, growth velocity, pubertal height gain, age at menarche and metabolic control during puberty. Results: 39 patients, 51% female, 82% diagnosed less than five years before puberty. Fifty-four percent presented an average HbA1c between 8-10%, what we considered reasonable. There seems to be a trend towards an inverse association between HbA1c and the maximum speed of growth and pubertal height gain, although not statistically significant. These patients were taller than average at diagnosis (z-score: male 0.9; female: 0.5) and lost height during puberty, yet attained final heights within normal range and matching their target heights. Conclusions: Although HbA1c seems to negatively influence maximum growth rate and pubertal height gain, there was no compromise in final height in this group of patients.

Download full-text


Available from: Carolina Constant, Apr 17, 2014